Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong
· Delayed Price · Currency is HKD
31.98
+2.64 (9.00%)
Apr 29, 2026, 4:08 PM HKT
HKG:3378 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | - | -115.83 | -76.06 |
| Depreciation & Amortization | - | 5.37 | 1.01 |
| Other Amortization | - | 0.11 | 0.03 |
| Loss (Gain) From Sale of Investments | - | -1.62 | 33.1 |
| Stock-Based Compensation | - | 22.35 | 15.49 |
| Other Operating Activities | - | -7.28 | -20.62 |
| Change in Accounts Payable | - | -0.64 | 0.88 |
| Change in Other Net Operating Assets | - | -7.35 | -5.83 |
| Operating Cash Flow | - | -104.89 | -51.99 |
| Capital Expenditures | - | -6.21 | -4.23 |
| Sale (Purchase) of Intangibles | - | - | -0.55 |
| Investment in Securities | - | 99.91 | 94.63 |
| Other Investing Activities | - | 2.92 | 4.11 |
| Investing Cash Flow | - | 96.62 | 93.96 |
| Long-Term Debt Repaid | - | -3.81 | -1.16 |
| Net Debt Issued (Repaid) | - | -3.81 | -1.16 |
| Issuance of Common Stock | - | 12.84 | 91.38 |
| Other Financing Activities | - | -2.55 | - |
| Financing Cash Flow | - | 6.49 | 90.22 |
| Foreign Exchange Rate Adjustments | - | 1 | 0.03 |
| Net Cash Flow | - | -0.79 | 132.21 |
| Free Cash Flow | - | -111.1 | -56.23 |
| Free Cash Flow Margin | - | -5052.48% | -2214.49% |
| Free Cash Flow Per Share | - | -10.16 | -7.71 |
| Cash Income Tax Paid | - | 5.81 | 2.05 |
| Levered Free Cash Flow | - | 101.65 | - |
| Unlevered Free Cash Flow | - | 107.51 | - |
| Change in Working Capital | - | -7.99 | -4.95 |
Source: S&P Capital IQ. Standard template.
Financial Sources.